SCHEMBL30731998

SCHEMBL30731998

CC(C)(C)OC(=O)N1CCN(CC2CCNCC2)[C@H](C(F)(F)F)C1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.40
MAPT P10636 2/20 0.37
MEN1 O00255 1/20 0.37
ALDH1A1 P00352 1/20 0.37
KMT2A Q03164 1/20 0.37
DDB1 Q16531 1/20 0.35
CRBN Q96SW2 1/20 0.35
GBA1 P04062 1/20 0.35
HPGD P15428 1/20 0.34
TPSAB1 Q15661 2/20 0.34
TPSD1 Q9BZJ3 2/20 0.34
TPSG1 Q9NRR2 2/20 0.34
LIPE Q05469 2/20 0.34
CNR1 P21554 1/20 0.34
KDM4E B2RXH2 2/20 0.33
PKM P14618 1/20 0.33
RECQL P46063 1/20 0.33
THRB P10828 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30794224 1.00 NR1H2 (0.40) NR1H2MAPTMEN1ALDH1A1KMT2A
SCHEMBL30706087 0.84 NR1H2 (0.43) NR1H2MAPTMEN1ALDH1A1KMT2A
SCHEMBL30705910 0.84 NR1H2 (0.43) NR1H2MAPTMEN1ALDH1A1KMT2A
SCHEMBL30731895 0.83 NR1H2 (0.45) NR1H2MAPTMEN1ALDH1A1KMT2A
SCHEMBL26925170 0.83 NR1H2 (0.45) NR1H2MAPTMEN1ALDH1A1KMT2A
SCHEMBL26924600 0.83 CACNA2D1 (0.38) GBA1TPSAB1TPSD1TPSG1
SCHEMBL26924602 0.83 CACNA2D1 (0.38) GBA1TPSAB1TPSD1TPSG1
SCHEMBL24876558 0.80 NR1H2 (0.41) NR1H2MAPTMEN1ALDH1A1KMT2A
SCHEMBL31701545 0.79 KDM4E (0.42) MAPTMEN1KMT2AHPGDKDM4E
SCHEMBL28973193 0.78 NR1H2 (0.40) NR1H2MAPTMEN1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250276981-A1 TRICYCLIC QUINOLONE BCL6 BIFUNCTIONAL DEGRADERS Treeline Biosciences, Inc. 2025-09-04 US disclosed
EP-4536650-A1 TRICYCLIC QUINOLONE BCL6 BIFUNCTIONAL DEGRADERS Treeline Biosciences, Inc. (US) 2025-04-16 EP disclosed
US-20240287091-A1 TRICYCLIC QUINOLONE BCL6 BIFUNCTIONAL DEGRADERS Treeline Biosciences, Inc. 2024-08-29 US disclosed
WO-2023240038-A1 TRICYCLIC QUINOLONE BCL6 BIFUNCTIONAL DEGRADERS Treeline Biosciences, Inc. (US) 2023-12-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240287091-A1 TRICYCLIC QUINOLONE BCL6 BIFUNCTIONAL DEGRADERS BCL6, BCL6B, BCOR NR1H2 2653/4885MAPT 4397/4885MEN1 2311/4885
US-20250276981-A1 TRICYCLIC QUINOLONE BCL6 BIFUNCTIONAL DEGRADERS BCL6, BCL6B, BCOR NR1H2 2653/4885MAPT 4397/4885MEN1 2311/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.